Pharmaust Limited (AU:PAA) has released an update.
PharmAust Limited has announced the successful passing of several resolutions during its Annual General Meeting, including a notable company name change to Neurizon Therapeutics Limited, which is expected to be reflected on the ASX with a new ticker ‘NUZ’ next week. Additionally, the election of directors Mr. Sergio Duchini, Mr. Marcus Hughes, and Dr. Katie MacFarlane was confirmed, alongside the adoption of the Remuneration Report.
For further insights into AU:PAA stock, check out TipRanks’ Stock Analysis page.
